Skip to main content
SpringerLink
Log in
Book cover

Tumors and Tumor-Like Lesions of the Hepatobiliary Tract pp 549–586Cite as

Intrahepatic Cholangiocarcinomas (ICCs)

  • Reference work entry
  • First Online:

  • 235 Accesses

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a cholangiocellular malignancy arising in any portion of the intrahepatic biliary tract. ICC can develop from small bile ducts and then occupies a peripheral compartment of the liver, but it also occurs in perihilar intrahepatic ducts and has to be distinguished from perihilar/hilar carcinoma of extrahepatic ducts. Overall, ICC is a rare neoplasm that accounts for less than 2 % of all malignant solid tumors. In relation to bile ducts involved, ICC is classified as a bile duct type (conventional type), further subdivided into a small bile duct type (peripheral type) and a large bile duct type (perihilar type), and a bile ductular type (bile ductular carcinoma or cholangiolocellular carcinoma). Several systems of pathomorphological classification of ICC have been proposed. The most commonly used system of the Japanese Liver Cancer Study Group distinguished mass-forming ICC, periductal-infiltrating ICC, and intraductal growth ICC. In the setting of the novel category of intraductal papillary neoplasm of the bile duct (IPN-B), treated in a separate chapter, most cases of intraductal growth ICC can now be considered to be invasive forms of IPN-B.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   1,599.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   2,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abe M, Kondo S, Hirano S, Ambo Y, Tanaka E, Saito K, Morikawa T, Okushiba S, Katoh H (2005) Superficially spreading cholangiocarcinoma. Int J Gastrointest Cancer 35:89–94

    Article  PubMed  Google Scholar 

  • Adachi and Eguchi 2014. http://www.ncbi.nlm.nih.gov/pubmed/24027075

  • Ahn KS, Kang KJ, Kim YH, Lim TJ, Jung HR, Kang YN, Kwon JH (2012) Inflammatory pseudotumors mimicking intrahepatic cholangiocarcinoma of the liver; IgG4-positivity and its clinical significance. J Hepatobiliary Pancreat Sci 19:405–412

    Article  PubMed  Google Scholar 

  • Ahrendt SA, Nakeeb A, Pitt HA (2001) Cholangiocarcinoma. Clin Liver Dis 5:191–218

    Article  CAS  PubMed  Google Scholar 

  • Aishima et al. 2004. http://www.ncbi.nlm.nih.gov/pubmed/15105812

  • Aishima S, Oda Y (2014) Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci. doi:10.1002/jhpb.154

    Google Scholar 

  • Aishima S, Taguchi K, Terashi T, Matsuura S, Shimada M, Tsuneyoshi M (2003) Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Mod Pathol 16:1019–1027

    Article  PubMed  Google Scholar 

  • Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M (2006) Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behavior. Histopathology 49:35–44

    Article  CAS  PubMed  Google Scholar 

  • Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M (2007) Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and perihilar type. Am J Surg Pathol 31:1059–1067

    Article  PubMed  Google Scholar 

  • Aishima S, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M (2008) Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol 21:256–264

    Article  CAS  PubMed  Google Scholar 

  • Aishima S, Iguchi T, Nishihara Y, Fujita N, Taguuchi K, Taketomi A, Maehara Y, Tsuneyoshi M (2009) Decreased intratumoral arteries reflect portal tract destruction and aggressive characteristics in intrahepatic cholangiocarcinoma. Histopathology 54:452–461

    Article  PubMed  Google Scholar 

  • Aishima S, Fujita N, Mano Y, Iguchi T, Taketomi A, Maehara Y, Oda Y, Tsuneyoshi M (2010) p62+ hyaline inclusions in intrahepatic cholangiocarcinoma associated with viral hepatitis or alcoholic liver disease. Am J Clin Pathol 134:457–465

    Article  PubMed  Google Scholar 

  • Aishima S, Fujita N, Mano Y, Kubo Y, Tanaka Y, Taketomi A, Shirabe K, Maehara Y et al (2011) Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg Pathol 35:590–598

    Article  PubMed  Google Scholar 

  • Akatsu M, Ueda M, Shimazu M, Kawachi S, Tanabe M, Aiura K, Wakabayashi G, Sakamoto M et al (2005) Spontaneous rupture of a mass-forming type peripheral cholangiocarcinoma. J Gastroenterol Hepatol 20:162–164

    Article  PubMed  Google Scholar 

  • Al Hamoudi W, Khalaf H, Allam N, Al Sebayel M (2012) Coincidental occurrence of hepatocellular carcinoma and cholangiocarcinoma (collision tumors) after liver transplantation: a case report. Hepat Mon 12:e5871

    Article  PubMed  PubMed Central  Google Scholar 

  • Alpert LI, Zak FG, Werthamer S, Bochetto JF (1974) Cholangiocarcinoma: a clinicopathologic study of five cases with ultrastructural observations. Hum Pathol 5:709–728

    Article  CAS  PubMed  Google Scholar 

  • Altemeier WA, Gall EA, Zinninger MM, Hoxworth PI (1957) Sclerosing carcinoma of the major intrahepatic bile ducts. AMA Arch Surg 75:45–460

    Article  Google Scholar 

  • Antoniou et al. 2012. http://www.ncbi.nlm.nih.gov/pubmed/22717934

  • Audran M, Hingrat JY, Paineau J, Gaillard F, Cousin C, Grolleau JY, Hardy M, Visset J (1982) Paraneoplastic hypercalcemia disclosing cholangiocarcinoma. Remission after hepatectomy (in French). Gastroenterol Clin Biol 6:983–988

    CAS  PubMed  Google Scholar 

  • Bae JY, Park YN, Nakanuma Y, Lee WJ, Kim JY, Park C (2002) Intestinal type cholangiocarcinoma of intrahepatic large bile duct associated with hepatolithiasis – a new histologic subtype for further investigation. Hepatogastroenterology 49:628–630

    PubMed  Google Scholar 

  • Batheja N, Suriawinata A, Saxena R, Ionescu G, Schwartz M, Thung SN (2000) Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. Mod Pathol 13:1265–1268

    Article  CAS  PubMed  Google Scholar 

  • Berdah SV, Delpero JR, Garcia S, Hardwigsen J, Le Treut YP (1996) A western surgical experience of peripheral cholangiocarcinoma. Br J Surg 83:1517–1521

    Article  CAS  PubMed  Google Scholar 

  • Bertuccio P, Bosetti C, Levi F, Decarli A, Negri E, La Vecchia C (2013) A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Ann Oncol 24:1667–1674

    Article  CAS  PubMed  Google Scholar 

  • Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48:308–321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8:512–522

    Article  PubMed  PubMed Central  Google Scholar 

  • Bonetti F, Chilosi M, Pisa R, Novelli P, Zamboni G, Menestrina F (1983) Epithelial membrane antigen expression in cholangiocarcinoma. An useful immunohistochemical tool for differential diagnosis with hepatocarcinoma. Virchows Arch A Pathol Anat Histopathol 401:307–313

    Article  CAS  PubMed  Google Scholar 

  • Braconi C, Patel T (2010) Cholangiocarcinoma: new insights into disease pathogenesis and biology. Infect Dis Clin North Am 24:871–884

    Article  PubMed  PubMed Central  Google Scholar 

  • Cao J, Huang L, Liu C, Li J, Zhang X, Shen J, Shen J, Li J, Lu L, Xu F, Yan J, Wu M et al (2013) Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: a clinicopathologic study of 35 resected cases. J Gastroenterol Hepatol 28:1025–1031

    Article  PubMed  Google Scholar 

  • Capizzi PJ, Rosen CB, Nagorney DM (1992) Intermittent jaundice by tumor emboli from intrahepatic cholangiocarcinoma. Gastroenterology 103:1669–1673

    Article  CAS  PubMed  Google Scholar 

  • Cardinale V, Semeraro R, Torrice A, Gatto M, Napoli C, Bragazzi MC, Gentile R, Alvaro D (2010) Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors. World J Gastrointest Oncol 2:407–416

    Article  PubMed  PubMed Central  Google Scholar 

  • Cardinale V, Bragazzi MC, Carpino G, Torrice A, Fraveto A, Gentile R, Pasqualino V et al (2013) Cholangiocarcinoma: increasing burden of classifications. Hepatobiliary Surg Nutr 2:272–280

    PubMed  PubMed Central  Google Scholar 

  • Carlisle RT, Roberts CS (1999) Pathologic fracture of the humerus due to metastatic cholangiocarcinoma. South Med J 92:1216–1219

    Article  CAS  PubMed  Google Scholar 

  • Carter RF, Smiley WA (1950) Primary carcinoma of intrahepatic bile ducts. J Kans Med Soc 51:281–282

    CAS  PubMed  Google Scholar 

  • Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, Pinna A, Dvorchik I et al (1997) Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185:429–436

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen MF (1999) Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol 14:1144–1149

    Article  CAS  PubMed  Google Scholar 

  • Chen MF, Jan YY, Chen TC (1998) Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases. Ann Surg 227:63–69

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen TC, Ng KF, Kuo T (2001) Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component. Mod Pathol 14:527–532

    Article  CAS  PubMed  Google Scholar 

  • Chen Z, Yan JJ, Huang L, Wu MC, Yan YQ (2006) Lymph node metastasis of patients with intrahepatic cholangiocarcinoma (in Chinese). Zhonghua Wai Ke Za Zhi 44:454–457

    PubMed  Google Scholar 

  • Chiyomaru K, Takai T, Ohashi A, Nishigori C (2010) Necrolytic migratory erythema with cholangiocarcinoma: pseudoglucagonoma syndrome. Eur J Dermatol 20:238–239

    PubMed  Google Scholar 

  • Chong RW, Chung AY, Chew IW, Lee VK (2006) Ruptured peripheral cholangiocarcinoma with hemoperitoneum. Dig Dis Sci 51:874–876

    Article  PubMed  Google Scholar 

  • Chou ST, Chan CW (1976) Mucin-producing cholangiocarcinoma: an autopsy study in Hong Kong. Pathology 8:321–328

    Article  CAS  PubMed  Google Scholar 

  • Chou ST, Chan CW, Ng WL (1976) Mucin histochemistry of human cholangiocarcinoma. J Pathol 118:165–170

    Article  CAS  PubMed  Google Scholar 

  • Chow LTC, Ahuja AT, Kwong KH, Fung KSC, Lai CK, Lau JWY (1997) Mucinous cholangiocarcinoma: an unusual complication of hepatolithiasis and recurrent pyogenic cholangitis. Histopathology 30:491–494

    Article  CAS  PubMed  Google Scholar 

  • Chu KM, Lai ECS, Al-Hadeedi S, Arcilla CE, Lo CM, Liu CL, Fan ST (1997) Intrahepatic cholangiocarcinoma. World J Surg 21:301–306

    Article  CAS  PubMed  Google Scholar 

  • Chuang SC, Lee KT, Tsai KB, Sheen PC, Nagai E, Mizumoto K, Tanaka M (2004) Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers. World J Surg 28:995–1000

    Article  PubMed  Google Scholar 

  • Chuaysri C, Thuwajit P, Paupairoj A, Chau-In S, Suthipongchai T, Thuwajit C (2009) Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol Rep 21:957–969

    CAS  PubMed  Google Scholar 

  • Colombari R, Tsui WM (1995) Biliary tumors of the liver. Semin Liver Dis 15:402–413

    Article  CAS  PubMed  Google Scholar 

  • Corr BR, Mantia-Smaldone G, Cantor J, Livolsi VA, Furth E, Chu CS (2013) Metastatic cholangiocarcinoma to the ovary: a case series. Int J Gynecol Pathol 32:562–565

    Article  PubMed  Google Scholar 

  • Craigh JR, Peters RL, Edmondson HA (1989) Tumors of the liver and intrahepatic bile duct. In: Hartmann WH (ed) Atlas of tumor pathology, 2nd series, fascicle 26. Armed Forces Institute of Pathology, Washington, DC

    Google Scholar 

  • Davis JM, Sadasivan R, Dwyer T, Van Veldhuizen P (1994) Case report: cholangiocarcinoma and hypercalcemia. Am J Med Sci 307:350–352

    Article  CAS  PubMed  Google Scholar 

  • De Martel C, Plummer M, Franceschi S (2010) Cholangiocarcinoma: descriptive epidemiology and risk factors. Gastroenterol Clin Biol 34:173–180

    Article  PubMed  Google Scholar 

  • Dechaphunkul A, Kanngurn S, Dechsukhum C, Tanutit P, Khow-Ean U, Sunpaweravong P (2010) The significance of galectin-3 immunohistochemistry, clinical characteristics and liver imaging in differentiating intrahepatic cholangiocarcinoma from adenocarcinoma liver metastasis. J Med Assoc Thai 93:523–528

    PubMed  Google Scholar 

  • Ding et al. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23306848

  • El Rassi ZE, Partensky C, Scoazec JY, Henry L, Lombard-Bohas C, Maddern G (1999) Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 25:375–380

    Article  PubMed  Google Scholar 

  • Endo et al. 2008. http://www.ncbi.nlm.nih.gov/pubmed/18580211

  • Esposito I, Schirmacher P (2008) Pathological aspects of cholangiocarcinoma. HPB 10:83–86

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fan L, He F, Liu H, Zhu J, Liu Y, Yin Z, Wang L, Guo Y, Wang Z, Yan Q, Huang G (2011) CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 11:320

    Article  PubMed  PubMed Central  Google Scholar 

  • Farley DR, Weaver AL, Nagorney DM (1995) Natural history” of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 70:425–429

    Article  CAS  PubMed  Google Scholar 

  • Fornelli A, Bondi A, Jovine E, Eusebi V (2010) Intrahepatic cholangiocarcinoma resembling a thyroid follicular neoplasm. Virchows Arch 456:339–342

    Article  PubMed  Google Scholar 

  • Fu XH, Tang ZH, Zong M, Yang GS, Yao XP, Wu MC (2004) Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients. Hepatobiliary Pancreat Dis Int 3:279–283

    PubMed  Google Scholar 

  • Fujii T, Harada K, Katayanagi K, Kurumaya H, Nakanuma Y (2005) Intrahepatic cholangiocarcinoma with multicystic, mucinous appearance and oncocytic change. Pathol Int 55:206–209

    Article  PubMed  Google Scholar 

  • Fujimoto K, Kuroda J, Makino K, Hasegawa Y, Kuratsu J (2013) Skull metastasis from intrahepatic cholangiocarcinoma: report of 3 cases and review of the literature. Neurol Med Chir (Tokyo) 53:717–721

    Article  Google Scholar 

  • Fukushima K, Kido M, Fukumoto T, Hori Y, Kusunoki N, Tsuchida S, Takahashi M, Tanaka M et al (2011) A case report of intrahepatic cholangiocarcinoma diagnosed as lung cancer with liver metastasis treated with radiofrequency ablation (in Japanese). Gan To Kagaku Ryoho 38:2030–2032

    PubMed  Google Scholar 

  • Furubo S, Harada K, Shimonishi T, Katayanagi K, Tsui W, Nakanuma Y (1999) Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma. Histopathology 35:230–240

    Article  CAS  PubMed  Google Scholar 

  • Gatto M, Alvaro D (2010) New insights on cholangiocarcinoma. World J Gastrointest Oncol 2:136–145

    Article  PubMed  PubMed Central  Google Scholar 

  • Gentilini A, Rombouts K, Galastri S, Caligiuri A, Mingarelli E, Mello T, Marra F, Mantero S et al (2012) Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. J Hepatol 57:813–820

    Article  PubMed  CAS  Google Scholar 

  • Goldenberg IS (1953) Carcinoma of the biliary tract. Conn State Med J 17:977–984

    CAS  PubMed  Google Scholar 

  • Gore RM, Shelhamer RP (2007) Biliary tract neoplasms: diagnosis and staging. Cancer Imaging 7(Spec. No. A):S15–S23

    Article  PubMed  PubMed Central  Google Scholar 

  • Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D’Angelica M, DeMatteo RP et al (2006) Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 244:260–264

    Article  PubMed  PubMed Central  Google Scholar 

  • Gu FM, Gao Q, Shi GM, Zhang X, Wang J, Jiang JH, Wang XY, Shi YH, Ding ZB et al (2012) Intratumoral IL-17+ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma. Ann Surg Oncol 19:2506–2514

    Article  PubMed  Google Scholar 

  • Guest et al. 2014. http://www.ncbi.nlm.nih.gov/pubmed/24310400

  • Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Capellani A et al (2009) Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 33:1247–1254

    Article  PubMed  Google Scholar 

  • Güllüoglu MG, Ozden I, Poyanli A, Cevikbas U, Ariogul O (2007) Intraductal growth-type mucin-producing peripheral cholangiocarcinoma associated with biliary papillomatosis. Ann Diagn Pathol 11:34–38

    Article  PubMed  Google Scholar 

  • Hai S, Kubo S, Uenishi T, Yamamoto T, Tanaka H, Shuto T, Takemura S, Hirohashi K (2005) Postoperative survival in intrahepatic cholangiocarcinoma showing intraductal growth. Hepatogastroenterology 52:374–377

    PubMed  Google Scholar 

  • Hamada S, Satoh K, Hirota M, Kanno A, Ishida K, Umino J, Ito H, Kikuta K, Kume K et al (2011) Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma. Cancer Sci 102:150–156

    Article  CAS  PubMed  Google Scholar 

  • Han JK, Lee JM (2004) Intrahepatic intraductal cholangiocarcinoma. Abdom Imaging 29:558–564

    Article  CAS  PubMed  Google Scholar 

  • Hardeman et al. 2002. http://www.ncbi.nlm.nih.gov/pubmed/12472031

  • Hasita H, Komohara Y, Okabe H, Maduda T, Ohnishi K, Lei XF, Beppu T, Baba H, Takeya M (2010) Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. Cancer Sci 101:1913–1919

    Article  CAS  PubMed  Google Scholar 

  • Hayashi H, Maeda T, Adachi E, Shimada M, Matsumata T, Takenaka K (1995) Argyrophilic nucleolar organizer regions (AgNOR) of resected intrahepatic cholangiocellular carcinomas. Hepatogastroenterology 42:440–444

    CAS  PubMed  Google Scholar 

  • Hayashi H, Tani T, Tajima H, Shoji Y, Terai S, Onishi I, Takamura H, Kitagawa H et al (2011) Small intestinal metastasis from intrahepatic cholangiocarcinoma: report of a case. Surg Today 41:859–864

    Article  PubMed  Google Scholar 

  • Higashi M, Yonezawa S, Ho JJ, Tanaka S, Irimura T, Kim YS, Sato E (1999) Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 30:1347–1355

    Article  CAS  PubMed  Google Scholar 

  • Higashi M, Yamada N, Yokoyama S, Kitamoto S, Tabata K, Koriyama C, Batra SK et al (2012) Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma – mass forming type. Pathobiology 79:101–106

    Article  CAS  PubMed  Google Scholar 

  • Hirohashi K, Uenishi T, Kubo S, Yamamamoto T, Tanaka H, Shuto T, Yamasaki O, Horii K, Kinoshita H (2002a) Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 9:233–236

    Article  PubMed  Google Scholar 

  • Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Kinoshita H (2002b) Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49:326–329

    PubMed  Google Scholar 

  • Horie S, Endo K, Kawasaki H, Terada T (2000) Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathologic features. Virchows Arch 437:25–30

    Article  CAS  PubMed  Google Scholar 

  • Hui CK, Yuen MF, Tso WK, Ng IO, Chan AO, Lai CL (2003) Cholangiocarcinoma in liver cirrhosis. J Gastroenterol Hepatol 18:337–341

    Article  PubMed  Google Scholar 

  • Hyder O, Hatzaras I, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C et al (2013) Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 153:811–818

    Article  PubMed  PubMed Central  Google Scholar 

  • Igami T, Nagino M, Oda K, Nishio H, Ebata T, Yokoyama Y, Shimoyama Y (2009) Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 249:296–302

    Article  PubMed  Google Scholar 

  • Iguchi T, Yamashita N, Aishima S, Kuroda Y, Terashi T, Sugimachi K, Taguchi K, Taketomi A et al (2009) A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model. Oncology 76:293–300

    Article  PubMed  Google Scholar 

  • Ikegami T, Kayashima H, Sadanaga N, Morizono S, Nakashima A, Matsuura H, Shirabe K et al (2013) Composite small cell and mucinous carcinoma originating from the intrahepatic bile duct: report of a case. Surg Today 43:194–198

    Article  PubMed  Google Scholar 

  • Imai K, Yamamoto M, Ariizumi S (2010) Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion. Hepatogastroenterology 57:1333–1336

    PubMed  Google Scholar 

  • Imamura S, Suzuki H (2004) Head and neck metastases from occult abdominal primary site: a case report and literature review. Acta Otolaryngol 124:107–112

    Article  PubMed  Google Scholar 

  • Inaba K, Suzuki S, Yokoi Y, Ota S, Nakamura T, Konno H, Baba S, Takehara Y, Nakamura S (2003) Hepatic inflammatory pseudotumor mimicking intrahepatic cholangiocarcinoma: report of case. Surg Today 333:714–717

    Article  Google Scholar 

  • Isa et al. 2002. http://www.ncbi.nlm.nih.gov/pubmed/12063950

  • Ishak KG, Goodman ZD, Stocker JT (2001) Intrahepatic cholangiocarcinoma and other malignant biliary tumors. In: Ishak KG, Goodman ZD, Stocker JT (eds) Fascicle 31. Atlas of tumor pathology: tumors of the liver and intrahepatic bile ducts. Armed Forces Institute of Pathology, Washington, DC, pp 245–270

    Google Scholar 

  • Izumi R, Shima Y, Yabushita K, Watanabe T, Onoda H, Hirosawa H, Konishi K, Miyazaki I (1986) HCG-producing intrahepatic cholangiocarcinoma (in Japanese). Gan No Rinsho 32:1867–1871

    CAS  PubMed  Google Scholar 

  • Izumi S, Nakamura S, Mano S (2010) Large intrahepatic cholangiocarcinoma with tumor infiltrative lymphocytes and autoimmune hepatitis-like features. Case Rep Gastroenterol 4:46–51

    Article  PubMed  PubMed Central  Google Scholar 

  • Izzo F, Piccirillo M, Albino V, Botti G, Foggia M, Iodice R, Pagano F, Piccirillo G, Tornillo L et al (2010) Case report: appearance of an intestinal metastasis from intrahepatic cholangiocarcinoma occurring 5 years after resection of the primary tumor. Eur J Gastroenterol Hepatol 22:892–894

    Article  PubMed  Google Scholar 

  • Jan YY, Yeh CN, Yeh TS, Chen TC (2005) Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol 11:1779–1784

    Article  PubMed  PubMed Central  Google Scholar 

  • Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y et al (2005) Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 241:703–712

    Article  PubMed  PubMed Central  Google Scholar 

  • Jeong CY, Hah YS, Cho BI, Lee SM, Joo YT, Jung EJ, Jeong SH, Lee YJ, Choi SK et al (2012) Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma. Oncol Rep 28:1283–1292

    CAS  PubMed  Google Scholar 

  • Jhala et al. 2005. http://www.ncbi.nlm.nih.gov/pubmed/15794670

  • Jin GY, Lee JM, Yu HC, Mun WS, Kim CS (2002) Intraductal papillary cholangiocarcinoma with aneurismal dilatation: a case of the mimicking abscess. Hepatogastroenterology 49:1523–1525

    PubMed  Google Scholar 

  • Jung KS, Chun KH, Choi GH, Jeon HM, Shin HS, Park YN, Park JY (2013) Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports. BMC Res Notes 6:250

    Article  Google Scholar 

  • Kaczynski J, Hansson G, Wallerstedt S (1998) Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma – a study of 51 cases from a low-endemicity area. Acta Oncol 37:77–83

    Article  CAS  PubMed  Google Scholar 

  • Kajiyama K, Maeda T, Takenaka K, Sugimachi K, Tsuneyoshi M (1999) The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of ‘scirrhous-type’ and ‘nonscirrhous-type’ growth. Am J Surg Pathol 23:892–902

    Article  CAS  PubMed  Google Scholar 

  • Kakinoki K, Takemori Y, Noda Y, Hoso M (2000) An autopsy case of intrahepatic cholangiocarcinoma producing granulocyte-colony stimulating factor (in Japanese). Nippon Shokakibyo Gakkai Zasshi 97:1165–1169

    CAS  PubMed  Google Scholar 

  • Karabulut AA, Sahin S, Sahin M, Eksioglu M, Ustün H (2006) Paraneoplastic acrokeratosis of Bazex (Bazex’s syndrome): report of a female case associated with cholangiocarcinoma and review of the published work. J Dermatol 33:850–854

    Article  PubMed  Google Scholar 

  • Kayashima H, Taketomi A, Yamashita Y, Kuroda Y, Kitagawa D, Harimoto N, Tsujita E et al (2008) Liver metastasis with intraductal invasion originating from rectal cancer: report of a case. Surg Today 38:765–768

    Article  PubMed  Google Scholar 

  • Keeratichamroen S, Leelawat K, Thongtawee T, Narong S, Aegem U, Tujinda S, Praditphol et al (2011) Expression of CD24 in cholangiocarcinoma cells is associated with disease progression and reduced patient survival. Int J Oncol 39:873–881

    CAS  PubMed  Google Scholar 

  • Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806–813

    Article  PubMed  Google Scholar 

  • Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314

    Article  PubMed  Google Scholar 

  • Khan SA, Toledano MB, Taylor-Robinson SD (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10:77–82

    Article  CAS  Google Scholar 

  • Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD et al (2012) Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 56:848–854

    Article  PubMed  Google Scholar 

  • Khunamornpong S, Siriaunkgul S, Suprasert P, Pojchamarnwiputh S, Chiangmai WN et al (2007) Intrahepatic cholangiocarcinoma metastatic to the ovary: a report of 16 cases of an underemphasized form of secondary tumor in the ovary that may mimic primary neoplasia. Am J Surg Pathol 31:1788–1799

    Article  PubMed  Google Scholar 

  • Kiba T, Tsuda H, Pairojkul C, Inoue S, Sugimura T, Hirohashi S (1993) Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocarcinomas in Japan and Thailand. Mol Carcinog 8:312–318

    Article  CAS  PubMed  Google Scholar 

  • Kim YI, Yu ES, Kim ST (1989) Intraductal variant of peripheral cholangiocarcinoma of the liver in Clonorchis sinensis infection. Cancer 63:1562–1566

    Article  CAS  PubMed  Google Scholar 

  • Kim et al. 1999. http://www.ncbi.nlm.nih.gov/pubmed/10398901

  • Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD (2003) Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Mol Imaging 30:1467–1472

    Article  Google Scholar 

  • Kim SH, Lee CH, Kim BH, Kim WB, Yeom SK, Kim KA, Park CM (2012) Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 36:704–709

    Article  PubMed  Google Scholar 

  • Kitade M, Yoshiji H, Yamao J, Fujimoto M, Kojima H, Mitoro A, Namisaki T, Toyohara M et al (2005) Intrahepatic cholangiocarcinoma associated with central calcification and arterio-portal shunt. Intern Med 44:825–828

    Article  PubMed  Google Scholar 

  • Kobayashi et al. 2000. http://www.ncbi.nlm.nih.gov/pubmed/10861422

  • Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N, Nakashima T (1982) Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer 49:2144–2147

    Article  CAS  PubMed  Google Scholar 

  • Kokubo T, Itai Y, Nagao T (1990) Intrahepatic cholangiocarcinoma with cystic formation. Radiat Med 8:219–221

    CAS  PubMed  Google Scholar 

  • Kondo NI, Shirabe K, Mano Y, Taketomi A, Yoshizumi T, Ikegami T, Masuda T, Kayashima H et al (2012) Late recurrence after resection of mass-forming intrahepatic cholangiocarcinoma: report of a case. Surg Today 42:1210–1214

    Article  PubMed  Google Scholar 

  • Körner M, Hayes GM, Rehmann R, Zimmermann A, Scholz A, Wiedenmann B, Miller LJ et al (2006) Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. J Hepatol 45:825–835

    Article  PubMed  CAS  Google Scholar 

  • Kosriwong K, Menheniott TR, Giraud AS, Jearanaikon P, Sripa B, Limpaiboon T (2011) Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation cholangiocarcinoma. World J Gastroenterol 17:1631–1641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kozaka K, Sasaki M, Fujii T, Harada K, Zen Y, Sato Y, Sawada S, Minato H, Matsui O (2007) A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘bile ductular carcinoma’. Histopathology 51:390–400

    Article  CAS  PubMed  Google Scholar 

  • Kubo S, Kinoshita H, Hirohashi K, Hamba H (1995) Hepatolithiasis associated with cholangiocarcinoma. World J Surg 19:637–641

    Article  CAS  PubMed  Google Scholar 

  • Kubo S, Uenishi T, Yamamoto S, Hai S, Yamamoto T, Ogawa M, Takemura S, Shuto T et al (2004) Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type. Hepatol Res 29:223–227

    Article  PubMed  Google Scholar 

  • Kwon BJ, Rhim H, Kom YS, Koh BH, Cho OK (2000) Peripheral cholangiocarcinoma with extensive tumor thrombi in the portal venous system: case report. Abdom Imaging 25:615–617

    Article  CAS  PubMed  Google Scholar 

  • Kwon OS, Jun DW, Kim SH, Chung MY, Kim NI, Song MH, Lee HH, Kim SH et al (2007) Distant skeletal muscle metastasis from intrahepatic cholangiocarcinoma presenting as Budd-Chiari syndrome. World J Gastroenterol 13:3141–3143

    PubMed  PubMed Central  Google Scholar 

  • Labgaa I, Carrasco-Avino G, Fiel MI, Schwartz ME (2014) Pancreatic recurrence of intrahepatic cholangiocarcinoma: case report and review of the literature. World J Gastrointest Surg 6:65–69

    PubMed  PubMed Central  Google Scholar 

  • Lagana SM, Moreira RK, Remotti HE, Bao F (2013) Glutamine synthetase, heat shock protein-70, and glypican-3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver. Appl Immunohistochem Mol Morphol 21:254–257

    Google Scholar 

  • Langer F, von Wasiliewski R, Kreipe HH (2006) The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas (in German). Pathologe 27:244–250

    Article  CAS  PubMed  Google Scholar 

  • Law JK, Davis J, Buckley A, Salh B (2005) Intrahepatic cholangiocarcinoma presenting as the Budd-Chiari syndrome: a case report and literature review. Can J Gastroenterol 19:723–728

    Article  PubMed  Google Scholar 

  • Lazarides KN, Gores GJ (2005) Cholangiocarcinoma. Gastroenterology 128:1655–1667

    Article  Google Scholar 

  • Lee SK, Choi BI, Cho JM, Han JK, Kim YI, Han MC (1995) Cystic peripheral cholangiocarcinoma: sonography and CT. Abdom Imaging 20:131–132

    Article  CAS  PubMed  Google Scholar 

  • Leong AS, Sormunen RT, Tsui WM, Liew CT (1998) Hep Par 1 and selected antibodies in the immunohistochemical distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 33:318–324

    Article  CAS  PubMed  Google Scholar 

  • Levy M, Lin F, Xu H, Dhall D, Spaulding BO, Wang HL (2010) S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Hum Pathol 41:1210–1219

    Article  CAS  PubMed  Google Scholar 

  • Li H, Li C (2013) The CD79a (HM47/A9) antibody is effective in distinguishing between primary hepatocellular carcinoma and primary intrahepatic cholangiocarcinoma. Oncol Lett 5:1195–1198

    CAS  PubMed  PubMed Central  Google Scholar 

  • Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM (2014) Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. Mod Pathol 27:1163–1173

    Article  CAS  PubMed  Google Scholar 

  • Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819–827

    Article  PubMed  Google Scholar 

  • Lim JH, Kim YI, Park CK (2000) Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liver. Abdom Imaging 25:89–92

    Article  CAS  PubMed  Google Scholar 

  • Liu XF, Zhang H, Zhu SG, Zhou XT, Su HL, Xu Z, Li SJ (2006) Correlation of p53 gene mutation and expression of P53 protein in cholangio-carcinoma. World J Gastroenterol 12:4706–4709

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 211:277–287

    Google Scholar 

  • Liver Cancer Study Group of Japan (1997) Clinical and surgical findings. In: Liver Cancer Study Group of Japan (ed) Classification of primary liver cancer. First English edition. Kanehara Shuppan, Toyko, pp 1–22

    Google Scholar 

  • Lok T, Chen L, Lin F, Wang HL (2014) Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. Hum Pathol 45:394–400

    Article  CAS  PubMed  Google Scholar 

  • Low JJ, Chew SH, Chew SP, Han CC, Tay EH, Ho TH (2003) A rare case of ovarian carcinoma originating from primary intrahepatic cholangiocarcinoma. Case Rep Eur J Gynaecol Oncol 24:85–88

    CAS  Google Scholar 

  • Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M (1996) The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 9:901–909

    CAS  PubMed  Google Scholar 

  • Malhi H, Gores GJ (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45:856–867

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mall AS, Tyler MG, Ho SB, Krige JE, Kahn D, Spearman W, Myer L, Govender D (2010) The expression of MUC mucin in cholangiocarcinoma. Pathol Res Pract 206:805–809

    Article  CAS  PubMed  Google Scholar 

  • Man XB, Tang L, Zhang BH, Li SJ, Qiu XH, Wu MC, Wang HY (2005) Upregulation of gylpican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers. Liver Int 25:962–966

    Article  CAS  PubMed  Google Scholar 

  • Manikawa K, Oka K, Masuda A, Yonkawa N, Kashimura J, Nihei T (2010) Extensive endothelial replacement by tumor cells in the portal system: an autopsy case of intrahepatic cholangiocarcinoma. Pathol Int 60:591–594

    Article  Google Scholar 

  • Matsumura N, Yamamoto M, Aruga A, Takasagi K, Nakano M (2002) Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer 94:1770–1776

    Article  PubMed  Google Scholar 

  • Mimatsu K, Oida T, Kawasaki A, Kano H, Fukino N, Kida K, Kuboi Y, Amano S (2011) Long-term survival after resection of mass-forming type intrahepatic cholangiocarcinoma directly infiltrating the transverse colon and sequential brain metastasis: report of a case. Surg Today 41:1410–1413

    Article  PubMed  Google Scholar 

  • Minato H, Nakanuma Y (1993) Cell kinetic and morphological studies of human cholangiocellular carcinoma. Acta Pathol Jpn 43:111–120

    CAS  PubMed  Google Scholar 

  • Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, Kusama K, Soeda J, Ogawa S (2006) Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41:893–900

    Article  CAS  PubMed  Google Scholar 

  • Miyamoto J, Tatsuzawa K, Sasjima H, Mineura K (2007) Metastatic skull tumor from cholangiocarcinoma. Case Rep Neurol Med Chir (Tokyo) 47:132–135

    Article  Google Scholar 

  • Mizukami Y, Ohta H, Arisato S, Nakano Y, Murakami M, Orii Y, Saito H, Sakurai Y et al (1999) Case report: mucinous cholangiocarcinoma featuring a multicystic appearance and periportal collar in imaging. J Gastroenterol Hepatol 14:1223–1226

    Article  CAS  PubMed  Google Scholar 

  • Morimoto Y, Tanaka Y, Ito T, Nakahara M, Nakaba H, Nishida T, Fujikawa M, Ito T et al (2003) Long-term survival and prognostic factors in the surgical treatment of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10:432–440

    Article  PubMed  Google Scholar 

  • Mosnier JF, Kandel C, Cazals-Hatem D, Bou-Hanna C, Gounay J, Jarry A, Laboisse CL (2009) N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas. Mod Pathol 22:182–190

    Article  CAS  PubMed  Google Scholar 

  • Muenphom K, Limpaiboon T, Jearanaikoon P, Pairojkul C, Sripa B, Budhisawasdi V (2006) Amplification of chromosome 21q22.3 harboring trefoil factor family gene in liver fluke related cholangiocarcinoma is associated with poor prognosis. World J Gastroenterol 12:4143–4148

    Article  Google Scholar 

  • Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Sueda T (2012) Intrahepatic cholangiocarcinoma: clinicopathological differences between peripheral type and hilar type. J Gastrointest Surg 16:540–548

    Article  PubMed  Google Scholar 

  • Nagano K, Fukuda Y, Nakano I, Katano Y, Toyoda H, Ebata M, Morita K, Yokozaki S et al (2000) A case of the development of two hepatocellular carcinomas and a cholangiocarcinoma with cirrhosis after elimination of serum hepatitis C virus RNA with interferon therapy. Hepatogastroenterology 47:1436–1438

    CAS  PubMed  Google Scholar 

  • Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Nakanishi K, Kamachi H, Kudo T et al (2005) Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 29:728–733

    Article  PubMed  Google Scholar 

  • Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S, Tanizawa Y, Kobayashi A (2003) Mucin-producing intrahepatic cholangiocarcinoma with portal vein thrombosis. Hepatogastroenterology 50:2194–2195

    PubMed  Google Scholar 

  • Nakajima T, Kondo Y (1989) Well-differentiated cholangiocarcinoma: diagnostic significance of morphologic and immunohistochemical parameters. Am J Surg Pathol 13:569–573

    Article  CAS  PubMed  Google Scholar 

  • Nakajima T, Kondo Y (1990) A clinicopathologic study of intrahepatic cholangiocarcinoma containing a component of squamous cell carcinoma. Cancer 65:1401–1404

    Article  CAS  PubMed  Google Scholar 

  • Nakajima T, Kondo Y, Miyazaki M, Okui K (1988) A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 19:1228–1234

    Article  CAS  PubMed  Google Scholar 

  • Nakanishi D, Tanio Y, Tagawa H, Akiyama T, Takashima J, Motone M, Kawai T, Kondo T et al (2013) An autopsy of a case of pulmonary hypertension secondary to pulmonary embolization of intrahepatic cholangiocarcinoma (in Japanese). Gan To Kagaku Ryoho 40:499–502

    PubMed  Google Scholar 

  • Nakanuma Y (2012) Classification of intrahepatic cholangiocarcinoma based on recent progress and new proposal. Nihon Shokakibyo Gakkai Zasshi 109:1865–1871

    PubMed  Google Scholar 

  • Nakanuma Y, Harada K, Ishikawa A, Zen Y, Sasaki M (2003) Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10:265–281

    Article  PubMed  Google Scholar 

  • Nakanuma Y, Sasaki M, Ikeda H, Sato Y, Zen Y, Kosaka K, Harada K (2008) Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatol Res 38:325–334

    Article  PubMed  Google Scholar 

  • Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Iheda H (2010) Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol 2:419–427

    Article  PubMed  PubMed Central  Google Scholar 

  • Nakanuma Y, Xu J, Harada K, Sato Y, Saski M, Ikeda H, Kim J, Yu E (2011) Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases. Pathol Int 61:298–305

    Article  CAS  PubMed  Google Scholar 

  • Nakanuma Y, Sato Y, Ikeda H, Harada K, Kobayashi M, Sano K, Uehara T, Yamamoto M et al (2012) Intrahepatic cholangiocarcinoma with predominant “ductal plate malformation” pattern: a new subtype. Am J Surg Pathol 36:1629–1635

    Article  PubMed  Google Scholar 

  • Nakanuma Y, Sato Y, Ojima H, Kanai Y, Aishima S, Yamamoto M, Ariizumi S, Furukawa T et al (2014) Clinicopathological characterization of so-called “cholangiocarcinoma with intraductal papillary growth” with respect to “intraductal papillary neoplasm of bile duct (IPNB)”. Int J Clin Exp Pathol 7:3112–3122

    PubMed  PubMed Central  Google Scholar 

  • Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH et al (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224:463–473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nishihara Y, Aishima S, Hayashi A, Iguchi T, Fujita N, Taketomi A, Honda H, Tsuneyoshi M (2009) CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma. Histopathology 55:423–431

    Article  PubMed  Google Scholar 

  • Nishizawa T, Higuchi H, Takaishi H, Iizuka H, Izumiya M, Yamagishi Y, Hisamatsu T et al (2006) A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy (in Japanese). Gan To Kagaku Ryoho 33:1657–1659

    PubMed  Google Scholar 

  • Nonomura A, Ohta G, Hayashi M, Izumi R, Watanabe K, Takayanagi N, Matsubara F (1987) Immunohistochemical localization of ras p21 and carcinoembryonic antigens (CEA) in cholangiocarcinoma. Liver 7:142–148

    Article  CAS  PubMed  Google Scholar 

  • Nozaki Y, Yamamoto M, Ikai I, Yamamoto Y, Ozaki N, Fujii H, Nagahori K, Matsumoto Y et al (1998) Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer 83:1923–1929

    Article  CAS  PubMed  Google Scholar 

  • Ohashi K, Nakajima Y, Tsutsumi M, Kanehiro H, Fukuoka T, Hisanaga M, Taki J, Nakae D et al (1994) Clinical characteristics and proliferating activity of intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol 9:442–446

    Article  CAS  PubMed  Google Scholar 

  • Ohashi et al. 1995. http://www.ncbi.nlm.nih.gov/pubmed/7557145

  • Ohira et al. 2006. http://www.ncbi.nlm.nih.gov/pubmed/16565491

  • Ohta T, Nagakawa T, Ueda N, Nakamura T, Akiyama T, Ueno K, Miyazaki I (1991) Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis. Cancer 68:2217–2223

    Article  CAS  PubMed  Google Scholar 

  • Oikawa et al. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23175232

  • Okabe H, Beppu T, Hayashi H, Horino K, Masuda T, Komori H, Ishikawa S, Watanabe M et al (2009) Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:2555–2564

    Article  PubMed  Google Scholar 

  • Okabe H, Beppu T, Hayashi H, Ishiko T, Masuda T, Otao R, Horlad H, Jono H, Ueda M et al (2011) Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells. Ann Surg Oncol 18:1175–1184

    Article  PubMed  Google Scholar 

  • Okabe H, Beppu T, Ueda M, Hayashi H, Ishiko T, Masuda T, Otao R, Horlad H, Mima K et al (2012) Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts. Int J Cancer 131:2234–2241

    Article  CAS  PubMed  Google Scholar 

  • Okami J, Dono K, Sakon M, Tsujie M, Hayashi N, Fujiwara Y, Nagano H, Umeshita K et al (2003) Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe. J Gastrointest Surg 7:850–856

    Article  PubMed  Google Scholar 

  • Okamura Y, Harada A, Maeda A, Fujioka A, Horiba T, Ishigure K, Hirai A, Ito Y, Uesaka K (2008) Carcinomatous meningitis secondary to cholangiocarcinoma without other systemic metastasis. J Hepatobiliary Pancreat Surg 15:237–239

    Article  PubMed  Google Scholar 

  • Okaro AC, Deery AR, Hutchins RR, Davidson BR (2001) The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium. J Clin Pathol 54:927–932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M (1977) Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer 39:232–246

    Article  CAS  PubMed  Google Scholar 

  • Okuda K, Nakanuma Y, Miyazaki M (2002) Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 17:1049–1055

    Article  PubMed  Google Scholar 

  • Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M (2006) Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for a-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 21:869–873

    Article  CAS  PubMed  Google Scholar 

  • Oshiro T, Esaki M (2011) A case of intrahepatic cholangiocarcinoma with marked mucus production. Jpn J Clin Oncol 41:1388

    Article  PubMed  Google Scholar 

  • Palma AS, Liu Y, Childs RA, Herbert C, Wang D, Chai W, Feizi T (2011) The human epithelial carcinoma antigen recognized by monoclonal antibody AE3 is expressed on a sulfoglycolipid in addition to neoplastic mucins. Biochem Biophys Res Commun 408:548–552

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pandey D, Lee KH, Wong SY, Tan KC (2007) Adrenal metastasis from intrahepatic cholangiocarcinoma. Liver Int 27:1016

    Article  PubMed  Google Scholar 

  • Park SK, Kim YS, Kim SG, Jang JY, Moon JH, Lee MS, Kim BS, Koh ES, Park JM (2010) Detection of distant metastasis to skeletal muscle by 18F-FDG-PET in a case of intrahepatic cholangiocarcinoma. Korean J Hepatol 16:325–328

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V (1993) Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev 2:537–544

    CAS  PubMed  Google Scholar 

  • Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353–1357

    Article  CAS  PubMed  Google Scholar 

  • Patel T (2006) Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 3:33–42

    Article  PubMed  Google Scholar 

  • Patel T (2011) Cholangiocarcinoma – controversies and challenges. Nat Rev Gastroenterol Hepatol 8:189–200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patel SH, Kooby DA, Staley CA, Sarmiento JM, Maithel SK (2011) The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? HPB (Oxford) 13:605–611

    Article  Google Scholar 

  • Patsenker E, Wilkens L, Banz V, Osterreicher CH, Weimann R, Eisele S, Keogh A et al (2010) The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. J Hepatol 52:362–369

    Article  CAS  PubMed  Google Scholar 

  • Que et al. 1999. http://www.ncbi.nlm.nih.gov/pubmed/10573518

  • Radwan NA, Ahmed NS (2012) The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1. Diagn Pathol 7:149

    Article  PubMed  PubMed Central  Google Scholar 

  • Ravnborg L, Thomsen K (1993) Acanthosis nigricans and bile duct malignancy. Acta Derm Venereol 73:378–379

    CAS  PubMed  Google Scholar 

  • Regimbeau JM, Panis Y, Nemeth J, Pocard M, de Claviere G, Soyer P, Valleur P (2003) Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading. Hepatogastroenterology 50:21–23

    CAS  PubMed  Google Scholar 

  • Resende V, Roda R, Pedrosa MS (2012) Gallbladder papillary neoplasia associated with intrahepatic carcinoma and pancreaticobiliary malformation. Gastroenterol Res 5:245–248

    Google Scholar 

  • Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-hensch N, Kristiansen G, Jochum W (2010) Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Hum Pathol 41:1558–1565

    Article  CAS  PubMed  Google Scholar 

  • Rizvi and Gores 2013. http://www.ncbi.nlm.nih.gov/pubmed/24140396

  • Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P (2000) Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that of colorectal carcinoma metastasis. Am J Surg Pathol 24:870–876

    Article  CAS  PubMed  Google Scholar 

  • Sabit H, Tsuneyama K, Shimonishi T, Harada K, Cheng J, Ida H, Saku T, Saito K, Nakanuma Y (2001) Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma. Pathol Int 51:248–256

    Article  CAS  PubMed  Google Scholar 

  • Sanada Y, Kawashita Y, Okada S, Azuma T, Matsuo S (2014) Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma. World J Gastrointest Pathophysiol 5:188–199

    PubMed  PubMed Central  Google Scholar 

  • Sano T, Yamamoto J, Kosuge T, Inoue K, Shimada K, Takayama T, Yamazaki S, Sakamoto M et al (1996) Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case. Hepatogastroenterology 43:667–670

    CAS  PubMed  Google Scholar 

  • Sano T, Kamiya J, Nagino M, Uesaka K, Kondo S, Kanai M, Hayakawa N, Nimura Y (1999) Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:101–107

    Article  CAS  PubMed  Google Scholar 

  • Sasaki M, Nakanuma Y, Shimizu K, Izumi R (1995) Pathological and immunohistochemical findings in a case of mucinous cholangiocarcinoma. Pathol Int 45:781–786

    Article  CAS  PubMed  Google Scholar 

  • Sasaki M, Nakanuma Y, Kim YS (1996) Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology 24:1074–1078

    Article  CAS  PubMed  Google Scholar 

  • Sasaki M, Nakanuma Y, Ho SB, Kim YS (1998a) Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Am J Clin Pathol 109:302–308

    Article  CAS  PubMed  Google Scholar 

  • Sasaki A, Aramaki M, Kawano K, Morii Y, Nakashima K, Yoshida T, Kirano S (1998b) Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg 85:1206–1209

    Article  CAS  PubMed  Google Scholar 

  • Sasaki A, Kawano K, Aramaki M, Nakashima K, Yoshida T, Kitano S (1999) Immunohistochemical expression of cytokeratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver. J Surg Oncol 70:103–108

    Article  CAS  PubMed  Google Scholar 

  • Sasaki M, Tsuneyama K, Ishikawa A, Nakanuma Y (2003) Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. Hum Pathol 34:1337–1344

    Article  CAS  PubMed  Google Scholar 

  • Sasaki et al. 2004. http://www.ncbi.nlm.nih.gov/pubmed/15011869

  • Sasaki M, Ikeda H, Nakanuma Y (2007) Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. Prog Histochem Cytochem 42:61–110

    Article  CAS  PubMed  Google Scholar 

  • Sato Y, Ojima H, Onaya H, Mori T, Hiraoka N, Kishi Y, Nara S, Esaki M, Shimada K et al (2013a) Histopathological characteristics of hypervascular cholangiocellular carcinoma as an early stage of cholangiocellular carcinoma. Hepatol Res. doi:10.1111/hepr.12236

    Google Scholar 

  • Sato Y, Harada K, Sasaki M, Nakanuma Y (2013b) Clinicopathological significance of S100 protein expression in cholangiocarcinoma. J Gastroenterol Hepatol 28:1422–1429

    Article  CAS  PubMed  Google Scholar 

  • Schlinkert RT, Nagorney DM, Van Heerden JA, Adson MA (1992) Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment. HPB Surg 5:95–101

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaje S, Fiel MI, Schwartz M, Thung SN (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31:49–60

    Article  PubMed  Google Scholar 

  • Settakorn J, Kaewpila N, Burns GF, Leong AS (2005) FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma. J Clin Pathol 58:1249–1254

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–125

    Article  PubMed  Google Scholar 

  • Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128:620–626

    Article  PubMed  Google Scholar 

  • Sharma P, Jaffe PE, Bhattacharyya A (1997) Metastatic cholangiocarcinoma presenting as ovarian cancer: a rare Krukenberg tumor. Am J Gastroenterol 92:531–533

    CAS  PubMed  Google Scholar 

  • Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, Sui CJ, Yang JM (2009) Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 15:5976–5982

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shen FZ, Zhang BY, Feng YJ, Jia ZX, An B, Liu CC, Deng XY, Kulkarni AD, Lu Y (2010) Current research in perineural invasion of cholangiocarcinoma. J Exp Clin Cancer Res 29:24

    Article  PubMed  PubMed Central  Google Scholar 

  • Shibahara et al. 2004. http://www.ncbi.nlm.nih.gov/pubmed/14752841

  • Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K (2001) Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88:1463–1466

    Article  CAS  PubMed  Google Scholar 

  • Shimonishi T, Miyazaki K, Nakanuma Y (2000) Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver. Histopathology 37:55–63

    Article  CAS  PubMed  Google Scholar 

  • Shimonishi et al. 2001. http://www.ncbi.nlm.nih.gov/pubmed/11274640

  • Shinojima Y, Toma Y, Terui T (2006) Sweet syndrome associated with intrahepatic cholangiocarcinoma producing granulocyte colony-stimulating factor. Br J Dermatol 155:1103–1104

    Article  CAS  PubMed  Google Scholar 

  • Shinozaki A, Shibahara J, Noda N, Tanaka M, Aoki T, Kokudo N, Fukayama M (2011) Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch 459:73–80

    Article  CAS  PubMed  Google Scholar 

  • Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V et al (2013) Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 144:829–840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sinawat P, Hemsrichart V (1991) A histopathologic study of 61 cases of peripheral intrahepatic cholangiocarcinoma. J Med Assoc Thai 74:448–453

    CAS  PubMed  Google Scholar 

  • Singh P, Patel T (2006) Advances in diagnosis, evaluation and management of cholangiocarcinoma. Curr Opin Gastroenterol 22:294–299

    Article  PubMed  Google Scholar 

  • Sirica AE (2011) The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 9:44–54

    Article  PubMed  CAS  Google Scholar 

  • Sirica AE, Campbell DJ, Dumur CI (2011) Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 27:276–284

    Article  CAS  PubMed  Google Scholar 

  • Skopelitou A, Hadjiyannakis M, Alexopoulou V, Krikoni O, Kamina S, Agnantis N (1996) Topographical immunohistochemical expression of bcl-2 protein in human liver lesions. Anticancer Res 16:975–978

    CAS  PubMed  Google Scholar 

  • Slattery JM, Sahani DV (2006) What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist 11:913–922

    Article  PubMed  Google Scholar 

  • Sohda T, Shiga H, Nakane H, Wtanabe H, Takeshita M, Sakisaka S (2006) Cholangiocellular carcinoma that produced both granulocyte-colony-stimulating factor and parathyroid hormone-related protein. Int J Clin Oncol 11:246–249

    Article  PubMed  Google Scholar 

  • Soyer P, Pelage JP, Zidi SH, Boudiaf M, Rymer R (1998) Portal vein invasion by intrahepatic peripheral cholangiocarcinoma: a rare cause of portal hypertension. AJR Am J Roentgenol 171:1413–1414

    Article  CAS  PubMed  Google Scholar 

  • Sriurauranata S, Tengchaisri T, Sirisinha S (1996) Ultrastructural characteristics of liver fluke associated human cholangiocarcinoma cell lines. Southeast Asian. J Trop Med Public Health 27:57–62

    Google Scholar 

  • Stitnimankarn T, Thakerngpol K, Damrongsak C, Chinapak O, Sindhvananda K (1978) Ultrastructure of cholangiocarcinoma associated with opisthorchiasis. Southeast Asian J Trop Med Public Health 9:558–567

    CAS  PubMed  Google Scholar 

  • Stroescu C, Herlea V, Dragnea A, Popescu I (2006) The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. J Gastrointestin Liver Dis 15:9–14

    PubMed  Google Scholar 

  • Su et al. 2006. http://www.ncbi.nlm.nih.gov/pubmed/16125303

  • Subimerb C, Pinlaor S, Khuntikeo N, Leelayuwat C, Morris A, McGrath MS, Wongkham S (2010) Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Mol Med Rep 3:597–605

    CAS  PubMed  Google Scholar 

  • Suh KS, Roh HR, Koh YT, Lee KU, Park YH, Kim SW (2000) Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 31:12–17

    Article  CAS  PubMed  Google Scholar 

  • Suh KS, Chang SH, Lee HJ, Roh HR, Kim SH, Lee KU (2002) Clinical outcomes and apomucin expression of intrahepatic cholangiocarcinoma according the gross morphology. J Am Coll Surg 195:782–789

    Article  PubMed  Google Scholar 

  • Tada et al. 1996. http://www.ncbi.nlm.nih.gov/pubmed/8708074

  • Tajima Y, Kuroki T, Fukuda K, Tsuneoka N, Furui J, Kanematsu T (2004) An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma. Br J Surg 91:99–104

    Article  CAS  PubMed  Google Scholar 

  • Takahashi I, Nakamura Y, Suzuki Y, Mitsuhashi N, Niibe H, Osada J (1994) Case report: bone metastasis from cholangiocarcinoma showing unusual accumulation on bone scintigraphy and G67Ga scintigraphy. Br J Radiol 67:303–305

    Article  CAS  PubMed  Google Scholar 

  • Takamura M, Yamagiwa S, Wakai T, Tamura Y, Kamimura H, Kato T, Tsuchiya A et al (2010) Loss of liver-intestine cadherin in human intrahepatic cholangiocarcinoma promotes angiogenesis by up-regulating metal-responsive transcription factor-1 and placental growth factor. Int J Oncol 36:245–254

    CAS  PubMed  Google Scholar 

  • Takenaka M, Akiba J, Kawaguchi T, Niizeki T, Arinaga-Hino T, Sata M, Nakashima O et al (2013) Intrahepatic cholangiocarcinoma with sarcomatous change producing granulocyte-colony stimulating factor. Pathol Int 63:233–235

    Article  CAS  PubMed  Google Scholar 

  • Tamandl et al. 2009. http://www.ncbi.nlm.nih.gov/pubmed/19591163

  • Tanaka S, Sugimachi K, Shirabe K, Shimada M, Wands JR (2000) Expression and antitumor effects of TRAIL in human cholangiocarcinoma. Hepatology 32:523–527

    Article  CAS  PubMed  Google Scholar 

  • Tanaka K, Honna T, Kitano Y, Kuroda T, Tanaka K, Morikawa N, Matsuda H, Kawashima N et al (2005) Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report. J Clin Pathol 58:884–887

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mossner J, Wittekind C (1999) Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer 80:1069–1074

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tascilar M, Offerhaus GJ, Altink R, Argani P, Sohn TA, Yeo CJ, Cameron JL, Goggins M et al (2001) Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am J Clin Pathol 116:831–837

    Article  CAS  PubMed  Google Scholar 

  • Terada T, Matsunaga Y (2000) Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 33:961–966

    Article  CAS  PubMed  Google Scholar 

  • Terada T, Matsunaga Y (2001) S-100-positive nerve fibers in hepatocellular carcinoma and intrahepatic cholangiocarcinoma: an immunohistochemical study. Pathol Int 51:89–93

    Article  CAS  PubMed  Google Scholar 

  • Terada and Nakamura 1992. http://www.ncbi.nlm.nih.gov/pubmed/1348889

  • Terada T, Nakanuma Y (1993) An immunohistochemical survey of amylase isoenzymes in cholangiocarcinoma and hepatocellular carcinoma. Arch Pathol Lab Med 117:160–162

    CAS  PubMed  Google Scholar 

  • Terada T, Nakanuma Y (1994) Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma. Histopathology 25:143–150

    Article  CAS  PubMed  Google Scholar 

  • Terada T, Nakanuma Y (1996) Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas. Pathol Int 46:764–770

    Article  CAS  PubMed  Google Scholar 

  • Terada T, Kida T, Nakanuma Y, Noguchi T (1992) Extensive portal tumor thrombi with portal hypertension in an autopsy case of intrahepatic cholangiocarcinoma. Am J Gastroenterol 87:1513–1518

    CAS  PubMed  Google Scholar 

  • Terada T, Makimoto K, Terayama N, Suzuki Y, Nakanuma Y (1996a) Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. J Hepatol 24:706–712

    Article  CAS  PubMed  Google Scholar 

  • Terada T, Okada Y, Nakanuma Y (1996b) Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 23:1341–1344

    Article  CAS  PubMed  Google Scholar 

  • Terada et al. 1998. http://www.ncbi.nlm.nih.gov/pubmed/9490278

  • Thingstad T, Haavik S, Hansen K, Sletten K, Codington JF, Barsett H (1998) Human carcinoma-associated antigen (HCA), isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma: comparison with epiglycanin. Eur J Pharm Sci 6:121–129

    Article  CAS  PubMed  Google Scholar 

  • Thorbjarnarson B (1959) Carcinoma of the bile ducts. Cancer 12:708–713

    Article  CAS  PubMed  Google Scholar 

  • Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ (1997) Cholangiocarcinoma: a review. Gastroenterologist 5:306–315

    CAS  PubMed  Google Scholar 

  • Tokodai K, Kawagishi N, Miyagi S, Takeda I, Sato K, Akamatsu Y, Sekiguchi S, Ishida K et al (2012) Intestinal obstruction caused by colonic metastasis from intrahepatic cholangiocarcinoma 6 years after removal of the primary tumor: report of a case. Surg Today 42:797–800

    Article  PubMed  Google Scholar 

  • Toriyama E, Nanashima A, Hayashi H, Abe K, Kinoshita N, Yuge S, Nagayasu T, Uetani M et al (2010) A case of intrahepatic clear cell cholangiocarcinoma. World J Gastroenterol 16:2571–2576

    Article  PubMed  PubMed Central  Google Scholar 

  • Torres T, Velho GC, Selores M (2010) Disseminated superficial porokeratosis in a patient with cholangiocarcinoma: a paraneoplastic manifestation? An Bras Dermatol 85:229–231

    Article  PubMed  Google Scholar 

  • Trikudanathan G, Dasanu CA (2010) Cholangiocarcinoma and paraneoplastic hypercalcemia: a lethal combination revisited. South Med J 103:716–718

    Article  PubMed  Google Scholar 

  • Tsai JH, Huang WC, Kuo KT, Yuan RH, Chen YL, Jeng YM (2012) S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas. Histopathology 61:1106–1116

    Article  PubMed  Google Scholar 

  • Tsuji T, Hiraoka T, Kanemitsu K, Takamori H, Tanabe D, Tashiro S (2001) Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 129:401–407

    Article  CAS  PubMed  Google Scholar 

  • Uchida M, Takahashi T, Sugiyama M, Takahashi K, Asakura H, Kamura T, Ajioka Y (1998) An autopsy case of the diffuse type of cholangiocellular carcinoma associated with extensive portal thrombi and acute hepatic failure (in Japanese). Nihon Shokakibyo Gakkai Zasshi 95:791–795

    CAS  PubMed  Google Scholar 

  • Uenishi T, Hirohashi K, Haba T, Wakasa K, Kubo S, Shuto T, Tanaka H, Yamamoto T, Tanaka S, Kinoshita H (2003) Portal thrombosis due to intrahepatic cholangiocarcinoma following successful treatment for hepatocellular carcinoma. Hepatogastroenterology 50:1140–1142

    PubMed  Google Scholar 

  • Uno M, Shimada K, Yamamoto Y, Nara S, Esaki M, Sakamoto Y, Kosuge T, Ojima H (2012) Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass. Surg Today 42:1189–1194

    Article  PubMed  Google Scholar 

  • Utispan K, Thuwajit P, Abiko Y, Charngkaew K, Paupairoj A, Chau-in S, Thuwajit C (2010) Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Mol Cancer 9:13

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Utispan K, Sonongbua J, Thuwajit P, Chau-In S, Pairojkul C, Wongkham S, Thuwajit C (2012) Periostin activates integrin a5b1 through a PI3K/AKT-dependent pathway in invasion of cholangiocarcinoma. Int J Oncol 41:1110–1118

    CAS  PubMed  Google Scholar 

  • Valverde A, Bonhomme N, Farges O, Sauvanet A, Flejou JF, Belghiti J (1999) Resection of intrahepatic cholangiocarcinoma: a western experience. J Hepatobiliary Pancreat Surg 6:122–127

    Article  CAS  PubMed  Google Scholar 

  • Van Beers BE (2008) Diagnosis of cholangiocarcinoma. HPB (Oxford) 10:87–93

    Article  Google Scholar 

  • Vasilieva LE, Papadhimitriou SI, Dourakis SP (2012) Modern diagnostic approaches to cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 11:349–359

    Article  PubMed  Google Scholar 

  • Vij K, Wang HL (2008) Aberrant expression of a-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence. Int J Surg Pathol 16:194–198

    Article  CAS  PubMed  Google Scholar 

  • Wachsberg RH, Levine CD, Cho KC, Simmons MZ, Khan MY, Koneru B (1996) Wedge-shaped intrahepatic cholangiocarcinoma: MRI-pathologic correlation. Abdom Imaging 21:219–221

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Zhang J, Chen J (2000) Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods (in Chinese). Zhongguo Yi Xue Ke Xue Yuan Xue Bao 22:57–60

    PubMed  Google Scholar 

  • Washington K, Gottfried MR (1996) Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 16:99–104

    Article  CAS  PubMed  Google Scholar 

  • Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Frankel WL et al (2010) Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts. Arch Pathol Lab Med 134:e14–e18

    PubMed  Google Scholar 

  • Weinbren K, Mutum SS (1983) Pathological aspects of cholangiocarcinoma. J Pathol 139:217–238

    Article  CAS  PubMed  Google Scholar 

  • Xiao P, Shi H, Zhang H, Meng F, Peng J, Ke Z, Wang K, Liu Y, Han A (2012) Epstein-Barr virus-associated intrahepatic cholangiocarcinoma bearing an intense lymphoplasmacytic infiltration. J Clin Pathol 65:570–573

    Article  PubMed  Google Scholar 

  • Xu HL, Inagaki Y, Seyama Y, Sugawara Y, Kokudo N, Nakata M, Wang FS, Tang W (2009) Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion. Life Sci 85:395–400

    Article  CAS  PubMed  Google Scholar 

  • Xu et al. 2011. http://www.ncbi.nlm.nih.gov/pubmed/22175889

  • Xu J, Igarashi S, Sasaki M, Matsubara T, Yoneda N, Kozaka K, Ikeda H, Kim J, Yu E et al (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 32:1156–1164

    Article  PubMed  Google Scholar 

  • Yamada S, Sanefuki H, Morimoto H, Harada Y, Mine S, Morimoto I, Eto S (2000) Parathyroid hormone-related peptide producing cholangiocellular carcinoma with a marked psammoma formation. J Gastroenterol Hepatol 15:1442–1446

    Article  CAS  PubMed  Google Scholar 

  • Yamada M, Shiroeda H, Shiroeda S, Sato K, Arisawa T, Tsutsumi M (2009) Cholangiocarcinoma producing parathyroid hormone-related peptide treated with chemoradiation using gemcitabine and S-1. Intern Med 48:2097–2100

    Article  PubMed  Google Scholar 

  • Yamamoto M, Ariizumi S (2011) Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today 41:896–902

    Article  PubMed  Google Scholar 

  • Yamamoto J, Kosuge T, Shimada K, Takayama T, Yamasaki S, Ozaki H, Makuuchi M (1993) Intrahepatic cholangiocarcinoma: proposal of new macroscopic classification (in Japanese). Nippon Geka Gakkai Zasshi 94:1194–1200

    CAS  PubMed  Google Scholar 

  • Yamamoto M, Takasaki K, Ootsubo T, Yoshikawa T, Nakamura M, Hanyu F (1994) Gross appearance and corresponding clinicopathological features of cholangiocellular carcinoma. Nippon Shokaki Geka Gakkai Zasshi 27:52–55

    Article  Google Scholar 

  • Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Sakamoto M, Hirohashi S et al (1997) Intrahepatic cholangiocarcinoma presenting intrabile duct extension: clinicopathologic study of five resected cases. Jpn J Clin Oncol 27:18–21

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto M, Takasaki K, Nakano M, Saito A (1998) Minute nodular intrahepatic cholangiocarcinoma. Cancer 82:2145–2149

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto M, Takasaki K, Yoshikawa T (1999) Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol 29:147–150

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto M, Takasaki N, Otsubo T, Katsuragawa H, Katagiri S (2001) Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 8:154–157

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto N, Shiraki K, Yamanaka Y, Sugimoto K, Murata K, Nakano T (2004) Images of interest. Hepatobiliary and pancreatic: cholangiocarcinoma with chylous ascites. J Gastroenterol Hepatol 19:1417

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto Y, Shimada K, Sakamoto Y, Esaki M, Nara S, Ban D, Kosuge T, Ojima H (2009) Clinicopathological characteristics of intrahepatic cholangiocarcinoma presenting intrahepatic bile duct growth. J Surg Oncol 99:161–165

    Article  PubMed  Google Scholar 

  • Yamanaka N, Okamoto E, Ando T, Oriyama T, Fujimoto J, Furukawa K, Tanaka T et al (1995) Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 76:2449–2456

    Article  CAS  PubMed  Google Scholar 

  • Yamasaki 2003. http://www.ncbi.nlm.nih.gov/pubmed/1459814

  • Yamashita K, Yonezawa S, Tanaka S, Shirahama H, Sakoda K, Imai K, Xing PX, McKenzie IF et al (1993) Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer 55:82–91

    Article  CAS  PubMed  Google Scholar 

  • Yang J, Yan LN (2008) Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol 14:6289–6297

    Article  PubMed  PubMed Central  Google Scholar 

  • Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schönleben F (2009) Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year western single-center experience in 107 patients. Ann Surg Oncol 16:404–412

    Article  PubMed  Google Scholar 

  • Yeh CN, Jan YY, Yeh TS, Hwang TL, Chen F (2004) Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol 11:606–611

    Article  PubMed  Google Scholar 

  • Yeh TS, Tseng JH, Chen TC, Liu NJ, Chiu CT, Jan YY, Chen MF (2005) Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology 42:657–664

    Article  PubMed  Google Scholar 

  • Yeh CN, Pang ST, Wu RC, Chen TW, Jan YY, Chen MF (2009) Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy. Oncol Rep 21:49–56

    CAS  PubMed  Google Scholar 

  • Yeh CN, Yeh TS, Chen TC, Jan YY, Chen MF (2013) Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy. J Gastroenterol 48:647–659

    Article  CAS  PubMed  Google Scholar 

  • Yen Y, Chu PG, Feng W (2004) Paraneoplastic syndromes in cancer: case 3. Parathyroid hormone-related hypercalcemia in cholangiocarcinoma. J Clin Oncol 22:2244–2245

    Article  PubMed  Google Scholar 

  • Yonezawa S, Higashi M, Yamada N, Yokoyama S, Goto M (2010) Significance of mucin expression in pancreatobiliary neoplasms. J Hepatobiliary Pancreat Sci 17:108–124

    Article  PubMed  Google Scholar 

  • Yoshida Y, Imai Y, Murakami T, Nishikawa M, Kurokawa M, Yonezawa T, Tokunaga K et al (1999) Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 24:66–68

    Article  CAS  PubMed  Google Scholar 

  • Zen Y, Sasaki M, Fujii T, Chen TC, Chen MF, Yeh TS, Jan YY, Huang SF, Nimura Y et al (2006) Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct – an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 44:350–358

    Article  CAS  PubMed  Google Scholar 

  • Zen Y, Britton D, Mitra V, Pike I, Sarker D, Itoh T, Heaton N, Quaglia A (2014) Tubulin β-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma. Histopathology. doi:10.1111/his.12497

    Google Scholar 

  • Zhou et al. 2009. http://www.ncbi.nlm.nih.gov/pubmed/19294418

  • Zhou HB, Wang H, Zhou DX, Wang H, Wang Q, Zou SS, Hu HP (2010) Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients. World J Gastroenterol 16:881–885

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou DX, Wang H, Zhou H, Li S, Qu HX, Kou X, Li J, Wang H, Hu HP (2011) Over-expression of human carcinoma-associated antigen in intrahepatic cholangiocellular carcinoma. Biochem Biophys Res Commun 405:325–332

    Article  CAS  PubMed  Google Scholar 

  • Zimmermann A (2001) Tumors of the bile ducts – pathological aspects. Med Sci Monit 7(Suppl 1):91–100

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Bern, Bern, Switzerland

    Arthur Zimmermann

Authors
  1. Arthur Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur Zimmermann .

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this entry

Cite this entry

Zimmermann, A. (2017). Intrahepatic Cholangiocarcinomas (ICCs). In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-26956-6_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26956-6_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26954-2

  • Online ISBN: 978-3-319-26956-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation